TickerFactsScreenerDevelopers

Lineage Cell Therapeutics, Inc. (LCTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$3.52M2010: -$9.85M2011: -$18.69M2012: -$25.00M2013: -$55.99M2014: -$50.68M2015: -$65.81M2016: -$58.97M2017: -$38.90M2018: -$41.80M2019: -$38.88M2020: -$26.45M2021: -$49.21M2022: -$22.52M2023: -$24.73M2024: -$21.48M2025: -$36.62M-$36.62M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$36.62M-70.5%
2024-$21.48M+13.2%
2023-$24.73M-9.8%
2022-$22.52M+54.2%
2021-$49.21M-86.1%
2020-$26.45M+32.0%
2019-$38.88M+7.0%
2018-$41.80M-7.4%
2017-$38.90M+34.0%
2016-$58.97M+10.4%
2015-$65.81M-29.8%
2014-$50.68M+9.5%
2013-$55.99M-123.9%
2012-$25.00M-33.8%
2011-$18.69M-89.7%
2010-$9.85M-179.9%
2009-$3.52M—